liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Cellular effects and metabolic stability of N1-cyclicinosinediphosphoribose and its derivatives
University Medical Centre Hamburg-Eppendorf, Germany..
University of Bath, UK.
Peking University, Beijing, China.
Max-Planck-Institute for Neurobiology, Martinsried, Germany.
Show others and affiliations
2006 (English)In: British Journal of Pharmacology, ISSN 0007-1188, E-ISSN 1476-5381, Vol. 149, no 4Article in journal (Refereed) Published
Abstract [en]

Background and purpose:

Recently, a number of mimics of the second messenger cyclic ADP-ribose (cADPR) with replacement of adenosine by inosine were introduced. In addition, various alterations in the molecule ranging from substitutions at C8 of the base up to full replacement of the ribose moieties still retained biological activity. However, nothing is known about the metabolic stability and cellular effects of these novel analogues.

Experimental approach:

cADPR and the inosine-based analogues were incubated with CD38, ADP-ribosyl cyclase and NAD-glycohydrolase and metabolism was analysed by RP-HPLC. Furthermore, the effect of the analogues on cytokine expression and proliferation was investigated in primary T-lymphocytes and T-lymphoma cells.

Key results:

Incubation of cADPR with CD38 resulted in degradation to adenosine diphosphoribose. ADP-ribosyl cyclase weakly catabolised cADPR whereas NAD-glycohydrolase showed no such activity. In contrast, N1-cyclic inosine 5′-diphosphoribose (N1-cIDPR) was not hydrolyzed by CD38. Three additional N1-cIDPR analogues showed a similar stability. Proliferation of Jurkat T-lymphoma cells was inhibited by N1-cIDPR, N1-[(phosphoryl-O-ethoxy)-methyl]-N9-[(phosphoryl-O-ethoxy)-methyl]-hypoxanthine-cyclic pyrophosphate (N1-cIDP-DE) and N1-ethoxymethyl-cIDPR (N1-cIDPRE). In contrast, in primary T cells neither proliferation nor cytokine expression was affected by these compounds.

Conclusions and Implications:

The metabolic stability of N1-cIDPR and its analogues provides an advantage for the development of novel pharmaceutical compounds interfering with cADPR mediated Ca2+ signalling pathways. The differential effects of N1-cIDPR and N1-cIDPRE on proliferation and cytokine expression in primary T cells versus T-lymphoma cells may constitute a starting point for novel anti-tumor drugs.

Place, publisher, year, edition, pages
John Wiley & Sons, 2006. Vol. 149, no 4
Keyword [en]
cyclic ADP-ribose, ADP-ribosyl cyclase, CD38, T-lymphoma cell, primary T cell, stable analogues, calcium signalling, proliferation, cytokine expression, signal transduction
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-81991DOI: 10.1038/sj.bjp.0706869PubMedID: 16967053OAI: diva2:557240
Available from: 2012-09-27 Created: 2012-09-27 Last updated: 2012-10-03

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Bruhn, Sören
In the same journal
British Journal of Pharmacology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 40 hits
ReferencesLink to record
Permanent link

Direct link